Journal of Thrombosis and Haemostasis
Publisher: Elsevier · ISSN 1538-7836 · 95 articles
- Platelet sialylation as a window into GNE deficiency
- How endogenous factor IX antigen and crossreacting material positive status shape extended half-life factor IX pharmacokinetics
- Bypassing bleeding disorder of unknown cause?
- Use of factor concentrates for the management of perioperative bleeding: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis
- Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates
- The tissue factor-TFPI pathway as a therapeutic target in bleeding disorders of unknown cause
- Mathematical modeling of flow-mediated thrombin generation after treatment of postoperative bleeding in cardiac surgery with cardiopulmonary bypass
- Pseudonaja textilis venom factor Va circumvents natural regulatory mechanisms via a unique A2 domain region
- An inducible zebrafish model of thrombocytopenia enables in vivo drug screening and reveals fibroblast growth factor signaling as a key regulator of platelet regeneration
- Frailty assessment in people with hemophilia
- Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis
- Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: a case series
- Unmasking the link: pulmonary embolism risk and outcomes in adults with immune thrombocytopenia
- Enoxaparin for the treatment of placenta-derived fetal growth restriction (GROWTH): an open-label multicenter randomized trial
- Acute stress activates Piezo1 to drive neutrophil extracellular traps formation and aggravated arterial thrombosis
- Comparison of the effects of abelacimab, asundexian, and milvexian on medical device-induced clotting and thrombin generation in vitro
- Socioeconomic status and its association with venous thromboembolism during pregnancy and postpartum: results from a Dutch population-based study
- Clinical implications of ADAMTS-13 conformation ELISA in immune-mediated thrombotic thrombocytopenic purpura with undetectable ADAMTS-13 antigen
- The role of antifactor Xa monitoring in the dosing and administration of low-molecular-weight heparins in pregnancy: a systematic review and meta-analysis
- Plasma protein profile in patients with antiphospholipid syndrome and controls without antiphospholipid syndrome
- Pretest direct oral anticoagulant removal is highly effective in lupus anticoagulant testing while on direct oral anticoagulants: a real-life experience
- Association of limb fat distribution and plasma metabolites with the risk of venous thromboembolism
- Clinical Outcomes of Upper-Extremity Deep Vein Thrombosis According to Cancer Status and Catheter Association: A RIETE (Registro Informatizado de la Enfermedad TromboEmbólica) Registry Analysis
- Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
- Prevalence and thrombotic risk of platelet factor 4–dependent platelet-activating antibodies
- Characterization of a series of patients with GNE-related thrombocytopenia: insights into pathogenesis, diagnosis, and treatment
- Autosomal dominant thrombocytopenia caused by a heterozygous CYCS variant: a new family and literature review
- Nonhemostatic platelet-dependent protection against murine bacterial pneumonia
- Direct glycoprotein-specific platelet autoantibodies detected in a majority of patients with persistent chemotherapy-induced thrombocytopenia
- Immune parameters correlate with fibrinolysis and predict efficacy of ultrasound-assisted catheter-directed thrombolysis in acute pulmonary embolism